CLINICAL_TRIALS
trial_result
· 2016-05-12
Clinical Trial Update: Study to Assess the Safety and Tolerability of Single Doses of REGN1500 [Phase 1]
Summary
Phase 1 study evaluating the safety and tolerability of single doses of REGN1500 in hypertriglyceridemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Hypertriglyceridemia | Phase 1 | Status: COMPLETED